Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCITAKA
2013-005039-26Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tocilizumab in Takayasu arteritis (TAK), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2015; status: completed.
02
Drugs
tocilizumab
03
Conditions
Takayasu arteritis (TAK)
Beyond the preview
Go deeper on 2013-005039-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005039-26.